Ali Tehrani
2021 - Zymeworks
In 2021, Ali Tehrani earned a total compensation of $5.1M as Former President & CEO at Zymeworks, a 5% increase compared to previous year.
Compensation breakdown
| Option Awards | $3,625,121 |
|---|---|
| Salary | $593,092 |
| Stock Awards | $870,500 |
| Other | $21,924 |
| Total | $5,110,637 |
Tehrani received $3.6M in option awards, accounting for 71% of the total pay in 2021.
Tehrani also received $593.1K in salary, $870.5K in stock awards and $21.9K in other compensation.
Rankings
In 2021, Ali Tehrani's compensation ranked 2,552nd out of 12,415 executives tracked by ExecPay. In other words, Tehrani earned more than 79.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,552 out of 12,415 | 79th |
Division Manufacturing | 1,013 out of 5,501 | 82nd |
Major group Chemicals And Allied Products | 389 out of 2,371 | 84th |
Industry group Drugs | 340 out of 2,092 | 84th |
Industry Pharmaceutical Preparations | 222 out of 1,542 | 86th |
Source: SEC filing on November 25, 2022.
Tehrani's colleagues
We found five more compensation records of executives who worked with Ali Tehrani at Zymeworks in 2021.